9 results match your criteria: "Peking University Cancer Hospital and Beijing Institute for Cancer Research[Affiliation]"

[Advances in molecular genetics of mucosal melanoma].

Zhonghua Bing Li Xue Za Zhi

February 2023

Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Beijing Institute for Cancer Research, Beijing 100142, China.

View Article and Find Full Text PDF

[Progress in treatment for malignant pleural mesothelioma].

Zhonghua Jie He He Hu Xi Za Zhi

January 2022

Department of Thoracic Medical Oncology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Beijing Institute for Cancer Research, Beijing 100142, China.

Malignant pleural mesothelioma (MPM) is a kind of invasive malignant tumor originated from pleural tissue. The incidence of MPM is not high in the population, but the prognosis is very poor. The median survival time is only about 12 months.

View Article and Find Full Text PDF

The ability to differentiate between benign, suspicious, and malignant pulmonary nodules is imperative for definitive intervention in patients with early stage lung cancers. Here, we report that plasma protein functional effector sncRNAs (pfeRNAs) serve as non-invasive biomarkers for determining both the existence and the nature of pulmonary nodules in a three-stage study that included the healthy group, patients with benign pulmonary nodules, patients with suspicious nodules, and patients with malignant nodules. Following the standards required for a clinical laboratory improvement amendments (CLIA)-compliant laboratory-developed test (LDT), we identified a pfeRNA classifier containing 8 pfeRNAs in 108 biospecimens from 60 patients by sncRNA deep sequencing, deduced prediction rules using a separate training cohort of 198 plasma specimens, and then applied the prediction rules to another 230 plasma specimens in an independent validation cohort.

View Article and Find Full Text PDF

[Clinical impacts of the intratumoral heterogeneity of PD-L1 expression in non-small cell lung cancer].

Zhonghua Bing Li Xue Za Zhi

May 2021

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Beijing Institute for Cancer Research, Beijing 100142, China.

View Article and Find Full Text PDF

[The progress of Chinese surgery in 2017].

Zhonghua Wai Ke Za Zhi

April 2018

Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Beijing Institute for Cancer Research, Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Beijing 100142, China.

The article outlined the speeches of Surgeon Branch during the Annual Scientific Conference of Chinese Medical Association in 2018.From the perspectives of inheritance, innovation, standardization and improvement, it summarizes the major progress of Chinese surgery in 2017 and introduces the objectives and action plans of Chinese Medical Association Branch of Surgery this year.

View Article and Find Full Text PDF

[Thought of the present application situation and the future trends of minimally invasive surgery in colorectal cancer].

Zhonghua Wai Ke Za Zhi

July 2017

Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Beijing Institute for Cancer Research, Key Laboratory of Carcinogenesis and Tanslational Research (Ministry of Education), Beijing 100142, China.

Laparoscopic surgery has been increasingly used in rectal cancer surgery. Though there are still some controversies, most of the research results support that the outcome is similar for rectal cancer patients with either laparoscopic or open surgery, in term of short-term such as safety and efficacy and long-term such as oncologic outcome. Standardization of laparoscopic training together with the comprehensive management concept are the prerequisites of laparoscopic rectal cancer surgery.

View Article and Find Full Text PDF

A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma.

Mol Ther Nucleic Acids

March 2017

Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, 650 W. Baltimore St., Baltimore, MD 21201, USA. Electronic address:

Lung cancer is the leading cause of cancer-related death worldwide. Although advanced drugs have benefitted patients, therapeutic success has largely been hampered because of rapid development of resistance. Here we report that PIWI-interacting RNA likes (piR-Ls), a novel type of functional sncRNAs, play key roles in chemoresistance to cisplatin (CDDP)-based chemotherapy in lung squamous cell carcinoma (LSCC).

View Article and Find Full Text PDF

[Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].

Nan Fang Yi Ke Da Xue Xue Bao

January 2016

Key laboratory of Carcinogenesis and Translational Research of Ministry of Education, Department of Bone and Soft tissue tumors, Peking University Cancer Hospital and Beijing Institute for Cancer Research, Beijing 100142, China.E-mail:

Objective: To characterize the clinical features of desmoid tumor, assess the efficacy of conservative chemotherapy for inoperable desmoid tumor and analyze the prognostic factors.

Methods: From August 2009 to December 2013, 52 patients with inoperable desmoid tumor were treated in our department and received chemotherapy with vinorelbine combined with low-dose methotrexate. The clinical data of the patients were analyzed retrospectively.

View Article and Find Full Text PDF